- In June 2006, the Advisory Committee on Immunization Practices (ACIP) voted to recommend the first vaccine developed to prevent cervical cancer caused by certain types of genital human papillomavirus (HPV). The vaccine, Gardasilâ, protects against four HPV types, which together cause 70% of cervical cancers and 90% of genital warts.  The Food and Drug Administration (FDA) recently licensed this vaccine for use in girls/women, ages 9-26 years. The vaccine is given through a series of three shots over a six-month period. The HPV vaccine is now available.

Click here for the PDF.

- The HPV vaccine is now available.

- Progesterone therapy for prevention of preterm labor in at risk patients.
Click here for the PDF.

Links:
www.acog.org
www.menopause.org
www.atkins-md.medem.com/texashealthcare